Angiogenesis in cancer and other diseases
The DOI matches its Crossref record; 71 of the 72 references it cites were found in a registry or an index.
Abstract
Pathological angiogenesis is a hallmark of cancer and various ischaemic and inflammatory diseases. Concentrated efforts in this area of research are leading to the discovery of a growing number of pro- and anti-angiogenic molecules, some of which are already in clinical trials. The complex interactions among these molecules and how they affect vascular structure and function in different environments are now beginning to be elucidated. This integrated understanding is leading to the development of a number of exciting and bold approaches to treat cancer and other diseases. But owing to several unanswered questions, caution is needed.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The presence of vascularization is one of the landmarks of tumor environments [57,180].”
From The Tumor-on-Chip: Recent Advances in the Development of Microfluidic Systems to Recapitulate the Physiology of Solid Tumors (2019) · cites this paper as [180]
Citations
Cites
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Endostatin: an endogenous inhibitor of angiogenesis and tumor growth
O'Reilly, M. S., Boehm, T., Shing, Y., Fukai, N., Vasios, G., Lane, W. S., Flynn, E., Birkhead, J. R., Olsen, B. R., & Folkman, J. (1997) · Cell · doi:10.1016/s0092-8674(00)81848-6 · Cited by 4,486 · cited 1×
“This hypothesis formed the basis of the discovery of angiostatin, endostatin, vasculostatin and other endogenous inhibitors of angiogenesi”
BackgroundMechanisms of angiogenesis and arteriogenesis
Carmeliet, P. (2000) · Nature Medicine · doi:10.1038/74651 · Cited by 4,162 · cited 1×
“We now know there are various molecular players involved in these different mechanisms of vascular growt”
BackgroundSelf-citationAbnormal blood vessel development and lethality in embryos lacking a single VEGF allele
Carmeliet, P., Ferreira, V., Breier, G., Pollefeyt, S., Kieckens, L., Gertsenstein, M., Fahrig, M., Vandenhoeck, A., Harpal, K., Eberhardt, C., et al. (1996) · Nature · doi:10.1038/380435a0 · Cited by 4,117
Self-citationO'Reilly, M. (1994) · Cell · doi:10.1016/0092-8674(94)90200-3 · Cited by 3,345 · cited 1×
“This hypothesis formed the basis of the discovery of angiostatin, endostatin, vasculostatin and other endogenous inhibitors of angiogenesi”
BackgroundRole of HIF-1α in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis
Carmeliet, P., Dor, Y., Herbert, J.-M., Fukumura, D., Brusselmans, K., Dewerchin, M., Neeman, M., Bono, F., Abramovitch, R., Maxwell, P., et al. (1998) · Nature · doi:10.1038/28867 · Cited by 2,502 · cited 1×
“However, caution is warranted as these hypoxia-inducible factors could also control cell deat”
BackgroundSelf-citationRegulation of transport pathways in tumor vessels: Role of tumor type and microenvironment
Hobbs, S. K., Monsky, W. L., Yuan, F., Roberts, W. G., Griffith, L., Torchilin, V. P., & Jain, R. K. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.8.4607 · Cited by 2,438
Self-citationCancer Treatment by Targeted Drug Delivery to Tumor Vasculature in a Mouse Model
Arap, W., Pasqualini, R., & Ruoslahti, E. (1998) · Science · doi:10.1126/science.279.5349.377 · Cited by 2,054 · cited 1×
“In vivo selection of phage display libraries has recently yielded peptides (for example, amino-acid sequences RGD and NGR) that preferentially recognize vessels in subcutaneous tumours in mic”
BackgroundOpenings Between Defective Endothelial Cells Explain Tumor Vessel Leakiness
Hashizume, H., Baluk, P., Morikawa, S., McLean, J. W., Thurston, G., Roberge, S., Jain, R. K., & McDonald, D. M. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65006-7 · Cited by 1,689
Self-citationHelmlinger, G., Yuan, F., Dellian, M., & Jain, R. K. (1997) · Nature Medicine · doi:10.1038/nm0297-177 · Cited by 1,628
Self-citation
Research works printed but not linked: 8
- Greenblatt, M. & Shubik, P. Tumor angiogenesis: transfilter diffusion studies in the hamster by the transparant chamber technique. J. Natl Cancer Inst. 41, 111–124 (1968).
- Ehrmann, R. L. & Knoth, M. Choriocarcinoma: transfilter stimulation of vasoproliferation in the hamster cheek pouch studied by light and electron microscopy. J. Natl Cancer Inst. 41, 1329 –1341 (1968).
- Folkman, J. in Cancer Medicine (eds Holland, J. F. et al.) 132– 152 (Decker, Ontario, Canada, 2000).
- Chang, Y. S. et al. Abundance of neoplastic cells in vessel walls of human tumor xenografts. Proc. Am. Assoc. Cancer Res. (in the press).
- Seljelid, R., Jozefowski, S. & Sveinbjornsson, B. Tumor stroma. Anticancer Res. 19, 4809–4822 (1999).
- Buschmann, I. & Schaper, W. The pathophysiology of the collateral circulation (arteriogenesis). J. Pathol. 190, 338–342 (2000). · doi:10.1002/(sici)1096-9896(200002)190:3<338::aid-path594>3.0.co;2-7
- Carmeliet, P. & Collen, D. Transgenic mouse models in angiogenesis and cardiovascular disease. J. Pathol. 190, 387–405 (2000). · doi:10.1002/(sici)1096-9896(200002)190:3<387::aid-path595>3.0.co;2-r
- Tsuzuki, Y. et al. VEGF modulation by targeting HIF-1alpha/HRE/VEGF cascade differentially regulates vascular response and growth rate in tumors. Cancer Res. (in the press).
Cited by
Items 901–1,000 of 1,084
Efficient Delivery of Nerve Growth Factors to the Central Nervous System for Neural Regeneration
Xu, D., Wu, D., Qin, M., Nih, L. R., Liu, C., Cao, Z., Ren, J., Chen, X., He, Z., Yu, W., et al. (2019) · Advanced Materials · doi:10.1002/adma.201900727 · Cited by 160
Thrombospondin 1 inhibits inflammatory lymphangiogenesis by CD36 ligation on monocytes
Cursiefen, C., Maruyama, K., Bock, F., Saban, D., Sadrai, Z., Lawler, J., Dana, R., & Masli, S. (2011) · Journal of Experimental Medicine · doi:10.1084/jem.20092277 · Cited by 160
“Both the VEGF family (VEGF-A, -C, and -D; Folkman, 1995; Carmeliet and Jain, 2000; Enholm et al., 2001; Veikkola et al., 2001; Nagy et al., 2002; Podgrabinska et al., 2002; Saaristo et al., 2002; Stacker et al., 2002; Rissanen et al., 2003; Cursiefen et al., 2004b) and bFGF can induce the outgrowth of lymphatic vessel…”
BackgroundKudo, M. (2019) · Liver Cancer · doi:10.1159/000502905 · Cited by 160
Galambos, C., Ng, Y.-S., Ali, A., Noguchi, A., Lovejoy, S., D'Amore, P. A., & deMello, D. E. (2002) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.27.2.4703 · Cited by 160
Endothelial response to hypoxia: physiologic adaptation and pathologic dysfunction
Ten, V. S., & Pinsky, D. J. (2002) · Current Opinion in Critical Care · doi:10.1097/00075198-200206000-00008 · Cited by 160
van der Veldt, A. A. M., Eechoute, K., Gelderblom, H. A. J., Gietema, J. A., Guchelaar, H., van Erp, N. P., van den Eertwegh, A. J. M., Haanen, J. B. A. G., Mathijssen, R. H. J., & Wessels, J. A. M. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-1828 · Cited by 172
“Particularly, genetic variation in VEGFR-2 may affect sunitinib activity, because VEGFR-2 is expressed in the normal endothelium (17) and the tumor vasculature may develop from preexisting vessels of the host (18).”
Quantifying heterogeneity in human tumours using MRI and PET
Asselin, M., O’Connor, J. P. B., Boellaard, R., Thacker, N. A., & Jackson, A. (2012) · European Journal of Cancer · doi:10.1016/j.ejca.2011.12.025 · Cited by 171
Wooden Breast Myodegeneration of Pectoralis Major Muscle Over the Growth Period in Broilers
Sihvo, H.-K., Lindén, J., Airas, N., Immonen, K., Valaja, J., & Puolanne, E. (2016) · Veterinary Pathology · doi:10.1177/0300985816658099 · Cited by 160
“10 46 11 (24) 11 (100) 0 11 (100) 0 0 0 9 (82) 2 (18) 0 18 47 47 (100) 34 (72) 13 (28) 32 (68) 9 (19) 3 (6) 3 (6) 38 (81) 5 (11) 4 (9) 24 21 21 (100) 11 (52) 10 (48) 7 (33) 7 (33) 4 (19) 3 (14) 10 (48) 9 (43) 2 (10) 35 44 13 (37) 2 (15) 11 (85) 2 (15) 0 3 (23) 8 (62) 2 (15) 2 (15) 9 (70) 38 51 12 (24) 2 (17) 10 (83) 2…”
The endothelial tip-stalk cell selection and shuffling during angiogenesis
Chen, W., Xia, P., Wang, H., Tu, J., Liang, X., Zhang, X., & Li, L. (2019) · Journal of Cell Communication and Signaling · doi:10.1007/s12079-019-00511-z · Cited by 172
Abdollahi, A., Lipson, K. E., Sckell, A., Zieher, H., Klenke, F. M., Poerschke, D., Roth, A. K., Han, X., Krix, M., Bischof, M., et al. (2003) · PubMed · Cited by 178
Vascular Integrins in Tumor Angiogenesis: Mediators and Therapeutic Targets
Alghisi, G. C., & Rüegg, C. (2006) · Endothelium · doi:10.1080/10623320600698037 · Cited by 159
Tumor angiogenesis – A potential target in cancer chemoprevention
Bhat, T. A., & Singh, R. P. (2008) · Food and Chemical Toxicology · doi:10.1016/j.fct.2007.08.032 · Cited by 160
Syndecan-2 is essential for angiogenic sprouting during zebrafish development
Chen, E., Hermanson, S., & Ekker, S. C. (2004) · Blood · doi:10.1182/blood-2003-06-1783 · Cited by 159
Chatterjee, M., Ben‐Josef, E., Robb, R. N., Vedaie, M., Seum, S., Thirumoorthy, K., Palanichamy, K., Harbrecht, M. T., Chakravarti, A., & Williams, T. M. (2017) · Cancer Research · doi:10.1158/0008-5472.can-17-0604 · Cited by 165
“(32,33) These two points suggest that utilizing albumin-bound or – conjugated chemotherapies may serve as a way to transport and retain chemotherapy or other drugs in solid tumors and the tumor microenvironment selectively, resulting in enhanced benefit over non-albumin bound drugs.”
BackgroundExploiting Advanced Hydrogel Technologies to Address Key Challenges in Regenerative Medicine
Foyt, D. A., Norman, M. D. A., Yu, T. T. L., & Gentleman, E. (2018) · Advanced Healthcare Materials · doi:10.1002/adhm.201700939 · Cited by 150
Perspectives for Improving the Tumor Targeting of Nanomedicine via the EPR Effect in Clinical Tumors
Kim, J., Cho, H., Lim, D., Joo, M. K., & Kim, K. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241210082 · Cited by 180
“VEGF plays an important role in tumor angiogenesis, and due to that property, VEGF blockade has been tested in clinical trials [98,99].”
BackgroundInflammation in cancer: therapeutic opportunities from new insights
Xie, Y., Liu, F., Wu, Y., Zhu, Y., Jiang, Y., Wu, Q., Dong, Z., & Liu, K. (2025) · Molecular Cancer · doi:10.1186/s12943-025-02243-8 · Cited by 167
Jodele, S., Chantrain, C. F., Blavier, L., Lutzko, C., Crooks, G. M., Shimada, H., Coussens, L. M., & DeClerck, Y. A. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3770 · Cited by 159
“Endothelial cells, pericytes, fibroblasts, and inflammatory cells such as macrophages, neutrophils, and mast cells are not innocent bystanders at tumor sites and have a profound effect on the fate of tumor cells (3, 4).”
BackgroundCyanine-loaded lipid nanoparticles for improved in vivo fluorescence imaging
Texier, I., Goutayer, M., Da Silva, A., Guyon, L., Djaker, N., Josserand, V., Neumann, E., Bibette, J., & Vinet, F. (2009) · Journal of Biomedical Optics · doi:10.1117/1.3213606 · Cited by 158
The Behavior of Matrix Metalloproteinases and Their Inhibitors in Colorectal Cancer
Herszényi, L., Hritz, I., Lakatos, G., Varga, M., & Tulassay, Z. (2012) · International Journal of Molecular Sciences · doi:10.3390/ijms131013240 · Cited by 158
“These steps facilitate the tumor-related angiogenic reaction, which also require MMP activity [78,79,83–86].”
BackgroundA polymer nanoparticle with engineered affinity for a vascular endothelial growth factor (VEGF165)
Koide, H., Yoshimatsu, K., Hoshino, Y., Lee, S.-H., Okajima, A., Ariizumi, S., Narita, Y., Yonamine, Y., Weisman, A. C., Nishimura, Y., et al. (2017) · Nature Chemistry · doi:10.1038/nchem.2749 · Cited by 158
Wang, C., Chen, S., Wang, Y., Liu, X., Hu, F., Sun, J., & Yuan, H. (2018) · Advanced Materials · doi:10.1002/adma.201706407 · Cited by 158
Current Understanding on EGFR and Wnt/ -Catenin Signaling in Glioma and Their Possible Crosstalk
Paul, I., Bhattacharya, S., Chatterjee, A., & Ghosh, M. K. (2013) · Genes & Cancer · doi:10.1177/1947601913503341 · Cited by 151
Rayavarapu, R. G., Petersen, W., Ungureanu, C., Post, J. N., van Leeuwen, T. G. J. M., & Manohar, S. (2007) · International Journal of Biomedical Imaging · doi:10.1155/2007/29817 · Cited by 158
“When illuminated with pulsed laser light, a tumor site by virtue of its higher absorption with respect to the healthy background tissue, due to angiogenesis [28], will act as a source of bipolar photoacoustic pulses.”
BackgroundMunaut, C., Noël, A., Hougrand, O., Foidart, J., Boniver, J., & Deprez, M. (2003) · International Journal of Cancer · doi:10.1002/ijc.11313 · Cited by 159
“This process includes the degradation of the extracellular matrix (ECM) and the proliferation, migration and differentiation of endothelial cells, and is finely regulated by inhibitory and promoting factors.(1,2) Among positive factors, vascular endothelial growth factor (VEGF) has been proposed as the major endotheli…”
BackgroundLoktionov, A. S. (2003) · The Journal of Nutritional Biochemistry · doi:10.1016/s0955-2863(03)00032-9 · Cited by 181
“One of the determining elements of these later stages is tumor-associated angiogenesis that is connected with a distorted balance between diverse pro- and antiangiogenic factors [270,271], most of which are highly multifunctional.”
BackgroundInvolvement of Notch Signaling in Wound Healing
Chigurupati, S., Arumugam, T. V., Son, T. G., Lathia, J. D., Jameel, S., Mughal, M. R., Tang, S.-C., Jo, D.-G., Camandola, S., Giunta, M., et al. (2007) · PLoS ONE · doi:10.1371/journal.pone.0001167 · Cited by 156
“Notch signaling affected several behaviors of vascular endothelial cells that are critical for angiogenesis, a process critical for tissue repair as a wound heals [29–32].”
BackgroundNovel 4-amino-furo[2,3-d]pyrimidines as Tie-2 and VEGFR2 dual inhibitors
Miyazaki, Y., Matsunaga, S., Tang, J., Maeda, Y., Nakano, M., Philippe, R. J., Shibahara, M., Liu, W., Sato, H., Wang, L., et al. (2005) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2005.03.034 · Cited by 166
Micro-CT Imaging of Tumor Angiogenesis
Ehling, J., Theek, B., Gremse, F., Baetke, S., Möckel, D., Maynard, J., Ricketts, S.-A., Grüll, H., Neeman, M., Knuechel, R., et al. (2014) · The American Journal of Pathology · doi:10.1016/j.ajpath.2013.10.014 · Cited by 150
Zhao, S., Yang, W., & Lai, R. Y. (2010) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2010.10.029 · Cited by 157
Klein, D., Weißhardt, P., Kleff, V., Jastrow, H., Jakob, H. G., & Ergün, S. (2011) · PLoS ONE · doi:10.1371/journal.pone.0020540 · Cited by 170
“to be essential in physiologic as well as pathologic processes [1,2].”
BackgroundOvercoming key biological barriers to cancer drug delivery and efficacy
Kim, S. M., Faix, P. H., & Schnitzer, J. E. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.09.016 · Cited by 151
“Described by some to be a hallmark of cancer [54,55], sprouting angiogenic growth is induced by factors in the tumor microenvironment, the most important of which is vascular endothelial growth factor (VEGF).”
BackgroundGlomeruloid Microvascular Proliferation Orchestrated by VPF/VEGF
Brat, D. J., & Meir, E. G. V. (2001) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64025-4 · Cited by 179
“To this end, angiogenesis is being approached from a variety of research angles: genetic, biochemical, molecular biological, transgenic and knockout mouse models, and large scale clinical trials involving anti-angiogenesis regimens in cancer patients.(1,2) In this period of heightened research activity, enthusiasm, an…”
BackgroundVascular endothelial growth factor prolongs survival in a transgenic mouse model of ALS
Zheng, C., Nennesmo, I., Fadeel, B., & Henter, J. (2004) · Annals of Neurology · doi:10.1002/ana.20223 · Cited by 156
Early vascular benefits of statin therapy
Tsiara, S., Elisaf, M., & Mikhailidis, D. P. (2003) · Current Medical Research and Opinion · doi:10.1185/030079903125002225 · Cited by 157
Expression of Vascular Endothelial Growth Factor Receptors 1, 2, and 3 in Quiescent Endothelia
Witmer, A. N., Dai, J., Weich, H. A., Vrensen, G. F. J. M., & Schlingemann, R. O. (2002) · Journal of Histochemistry & Cytochemistry · doi:10.1177/002215540205000603 · Cited by 174
“However, long-term side effects are not yet known and it has already been implied that these therapies could affect normal tissues and physiological angiogenesis (Carmeliet and Jain 2000; Oosthuyse et al. 2001; Yano et al. 2001).”
BackgroundAngiogenesis and Vascular Architecture in Pheochromocytomas
Favier, J., Plouin, P., Corvol, P. L., & Gasc, J. (2002) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64400-8 · Cited by 164
“According to a commonly accepted concept, induction of angiogenesis is a condition for tumor growth beyond a certain size and for metastasis invasion.(6) This process of neovascularization, necessary to ensure the input of oxygen and nutrients, is regulated by hypoxia, which triggers the increased expression of variou…”
BackgroundChung, S., Sudo, R., Vickerman, V., Zervantonakis, I. K., & Kamm, R. D. (2010) · Annals of Biomedical Engineering · doi:10.1007/s10439-010-9899-3 · Cited by 154
Tumor vasculature and glioma stem cells: Contributions to glioma progression
Jhaveri, N., Chen, T. C., & Hofman, F. M. (2014) · Cancer Letters · doi:10.1016/j.canlet.2014.12.028 · Cited by 163
“01% endothelial cells dividing [26].”
BackgroundInfluentialHow cancer cells dictate their microenvironment: present roles of extracellular vesicles
Naito, Y., Yoshioka, Y., Yamamoto, Y., & Ochiya, T. (2017) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2346-3 · Cited by 148
“Angiogenesis within tumor tissue is required to provide nutrients and oxygen to cancer cells and allows entry to the blood circulation system [3, 77, 78].”
BackgroundShen, J., Rees, T. W., Ji, L., & Chao, H. (2021) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2021.214016 · Cited by 159
Cross-talk of Integrin α3β1 and Tissue Factor in Cell Migration
Dorfleutner, A., Hintermann, E., Tarui, T., Takada, Y., & Ruf, W. (2004) · Molecular Biology of the Cell · doi:10.1091/mbc.e03-09-0640 · Cited by 155
“4416 © 2004 by The American Society for Cell Biology sion, angiogenesis, and vascular remodeling (Mignatti and Rifkin, 1993; Werb, 1997; Carmeliet and Jain, 2000).”
BackgroundCirculating Monocytes Expressing CD31
Kim, S., Kim, J., Papadopoulos, J. N., Kim, S. W., Maya, M., Zhang, F., He, J., Fan, D., Langley, R. R., & Fidler, I. J. (2009) · American Journal Of Pathology · doi:10.2353/ajpath.2009.080819 · Cited by 171
3D bioprinting: improving in vitro models of metastasis with heterogeneous tumor microenvironments
Albritton, J. L., & Miller, J. S. (2017) · Disease Models & Mechanisms · doi:10.1242/dmm.025049 · Cited by 154
“Under physiologic conditions the ‘ angiogenic switch ’ , or balance between contributions of pro-and anti-angiogenic signals, remains ‘ off ’ unless external agents like tumor cells force the balance in favor of angiogenesis (Carmeliet and Jain, 2000; Folkman, 2002).”
Fang, B., Kovačević, Ž., Park, K. C., Kalinowski, D. S., Jansson, P. J., Lane, D. J. R., Sahni, S., & Richardson, D. R. (2013) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2013.11.002 · Cited by 166
“Angiogenesis is the process by which new blood vessels are formed from pre-existing vessels and it is well known to play an important role in multiple diseases, including cancer [242,243].”
BackgroundTumor stroma derived biomarkers in cancer
Sund, M., & Kalluri, R. (2009) · Cancer and Metastasis Reviews · doi:10.1007/s10555-008-9175-2 · Cited by 168
“This is related to the activation of angiogenesis, which is a crucial process in cancer progression and spreading [5, 6].”
BackgroundThienopyrimidine Ureas as Novel and Potent Multitargeted Receptor Tyrosine Kinase Inhibitors
Dai, Y., Guo, Y. P., Frey, R. R., Ji, Z., Curtin, M. L., Ahmed, A. A., Albert, D. H., Arnold, L. D., Arries, S. S., Barlozzari, T., et al. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm050458h · Cited by 163
Event extraction across multiple levels of biological organization
Pyysalo, S., Ohta, T., Miwa, M., Cho, H.-C., Tsujii, J., & Ananiadou, S. (2012) · Bioinformatics · doi:10.1093/bioinformatics/bts407 · Cited by 178
“The domain involves a tissue/organ-level process that is closely associated with cancer and other organism-level pathologies and whose molecular basis is increasingly understood (Carmeliet and Jain, 2000), and domain texts thus represent a good test case for structured IE across multiple levels of biological organizat…”
BackgroundAnticancer Properties of Flavonoids: Roles in Various Stages of Carcinogenesis
Clere, N., Faure, S., Martínez, M. C., & Andriantsitohaina, R. (2011) · Cardiovascular & Hematological Agents in Medicinal Chemistry · doi:10.2174/187152511796196498 · Cited by 163
“Moreover, various environmental stimuli such as oxygen deprivation (hypoxia) or acidic conditions, induction of oncogenes such as H-ras, v-Src and HER-2, silencing of tumor suppressor genes such as p53 [20, 21] or ROS production [22, 23] activate tumor angiogenesis through an overproduction of pro-angiogenic factors b…”
BackgroundBioprinting Vasculature: Materials, Cells and Emergent Techniques
Tomasina, C., Bodet, T., Mota, C., Moroni, L., & Camarero-Espinosa, S. (2019) · Materials · doi:10.3390/ma12172701 · Cited by 145
“Indeed, the diffusion limit of oxygen is said to be of 100–200 μm, depending on the tissue, and the cell survival above this limit appears to be compromised [5].”
BackgroundLee, H.-S., Amarakoon, D., Wei, C.-I., Choi, K. Y., Smolensky, D., & Lee, S.-H. (2021) · Food and Chemical Toxicology · doi:10.1016/j.fct.2021.112356 · Cited by 146
Imaging biomarkers for evaluating tumor response: RECIST and beyond
Ko, C., Yeh, L., Kuo, Y., & Chen, J. (2021) · Biomarker Research · doi:10.1186/s40364-021-00306-8 · Cited by 162
“The degree of CT perfusion is related to tumor aggressiveness in many types of cancer, and highly vascularized tumors are associated with a poor prognosis [54, 56, 57].”
BackgroundEstrogens and the Vascular Endothelium
Cid, M. C., Schnaper, H. W., & Kleinman, H. K. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb04211.x · Cited by 154
Mechanisms of Action of Bevacizumab as a Component of Therapy for Metastatic Colorectal Cancer
Ellis, L. M. (2006) · Seminars in Oncology · doi:10.1053/j.seminoncol.2006.08.002 · Cited by 172
Evidence of angiogenic vessels in Alzheimer’s disease
Desai, B. S., Schneider, J. A., Li, J.-L., Carvey, P. M., & Hendey, B. (2009) · Journal of Neural Transmission · doi:10.1007/s00702-009-0226-9 · Cited by 153
“Angiogenic vessels differ from patent vessels in that they have numerous fenestrea, widened inter-endothelial junctions, abnormal endothelial cell shapes, and abnormal basement membranes (Carmeliet and Jain 2000).”
Osusky, K. L., Hallahan, D. E., Fu, A., Ye, F., Shyr, Y., & Geng, L. (2004) · Angiogenesis · doi:10.1007/s10456-004-3149-y · Cited by 155
“At 216 h, in the implanted tumor, angiogenesis and vasculature remodeling [8, 10] were complete.”
BackgroundChen, M.-C., Hsu, W.-L., Hwang, P.-A., & Chou, T.-C. (2015) · Marine Drugs · doi:10.3390/md13074436 · Cited by 147
Magnetic Resonance Perfusion and Permeability Imaging in Brain Tumors
Lacerda, S., & Law, M. (2009) · Neuroimaging Clinics of North America · doi:10.1016/j.nic.2009.08.007 · Cited by 158
Multiscale Modelling of Fluid and Drug Transport in Vascular Tumours
Shipley, R. J., & Chapman, S. J. (2010) · Bulletin of Mathematical Biology · doi:10.1007/s11538-010-9504-9 · Cited by 172
“To obtain nutrients for growth, tumours sprout new blood vessels in a process called angiogenesis (Cameliet and Jain, 2000).”
BackgroundSadick, H., Riedel, F., Naim, R., GOESSLER, U. R., Hörmann, K., Hafner, M., & Lux, A. (2005) · PubMed · Cited by 153
Tuning Endothelial Permeability with Functionalized Nanodiamonds
Setyawati, M. I., Mochalin, V. N., & Leong, D. T. (2016) · ACS Nano · doi:10.1021/acsnano.5b06487 · Cited by 155
Tumor Neovascularization and Developments in Therapeutics
Katayama, Y., Uchino, J., Chihara, Y., Tamiya, N., Kaneko, Y., Yamada, T., & Takayama, K. (2019) · Cancers · doi:10.3390/cancers11030316 · Cited by 143
“, neovascularization) is required [3,4].”
Noninvasive photoacoustic imaging of the developing vasculature during early tumor growth
Lao, Y., Xing, D., Yang, S., & Xiang, L. (2008) · Physics in Medicine and Biology · doi:10.1088/0031-9155/53/15/013 · Cited by 153
Guenzi, E., Töpolt, K., Lubeseder–Martellato, C., Jörg, A., Naschberger, E., Benelli, R., Albini, A., & Stürzl, M. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg382 · Cited by 173
Modulating the Tumor Microenvironment to Enhance Tumor Nanomedicine Delivery
Zhang, B., Hu, Y., & Pang, Z. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00952 · Cited by 152
“The nanomedicines have to cross the blood vessel walls, penetrate the extravascular space, and eventually reach tumor cells to exert their therapeutic effects. thrombospondins (Carmeliet and Jain, 2000; Jain, 2003).”
BackgroundPrestwich, G. D. (2007) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21386 · Cited by 166
Angiogenesis: An Adaptive Dynamic Biological Patterning Problem
Secomb, T. W., Alberding, J. P., Hsu, R., Dewhirst, M. W., & Pries, A. R. (2013) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1002983 · Cited by 162
“To test this hypothesis and analyze the relations between biological mechanisms and system properties, we developed a theoretical model that integrates simulations of network blood flow, convective and diffusive oxygen transport, generation and diffusion of VEGF [5], stochastic sprouting angiogenesis [6], structural a…”
MethodSmeenge, M., Tranquart, F., Mannaerts, C. K., de Reijke, T. M., van de Vijver, M. J., Laguna, M. P., Pochon, S., de la Rosette, J. J. M. C. H., & Wijkstra, H. (2017) · Investigative Radiology · doi:10.1097/rli.0000000000000362 · Cited by 152
Dormond, O., Bezzi, M., Mariotti, A., & Rüegg, C. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m209213200 · Cited by 153
Aitkenhead, M., Wang, S., Nakatsu, M. N., Mestas, J., Heard, C. J., & Hughes, C. C. W. (2002) · Microvascular Research · doi:10.1006/mvre.2001.2380 · Cited by 163
“This suggests that seemingly small differences between these model systems can result in subtly different suites of genes being expressed, which is in good agreement with studies showing that angiogenesis in different tissues is not necessarily equivalent (Carmeliet and Jain, 2000).”
ResultHOXB7: a key factor for tumor-associated angiogenic switch.
Carè, A., Felicetti, F., Meccia, E., Bottero, L., Parenza, M., Stoppacciaro, A., Peschle, C., & Colombo, M. P. (2001) · PubMed · Cited by 169
Zhang, L., Yang, N., Conejo Garcia, J.-R., Mohamed, A., Benencia, F., Rubin, S. C., Allman, D., & Coukos, G. (2002) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64505-1 · Cited by 151
Tumor targeting of functionalized lipid nanoparticles: Assessment by in vivo fluorescence imaging
Goutayer, M., Dufort, S., Josserand, V., Royère, A., Heinrich, E., Vinet, F., Bibette, J., Coll, J., & Texier, I. (2010) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2010.02.007 · Cited by 161
“Even if fenestrations of the vasculature at the tumor sites strongly depend on the cancer models [38], 20–100 nm range often appears as an optimal diameter for an efficient extravasation and retention of the nanoparticles from capillaries to the tumor interstitial tissues [39].”
BackgroundBayless, K. J., & Davis, G. E. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2003.11.017 · Cited by 151
Surgery, wound healing, and metastasis: Recent insights and clinical implications
Ceelen, W. P., Pattyn, P., & Mareel, M. M. K. (2013) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2013.07.008 · Cited by 158
“VEGF Angiogenesis, lymphangiogenesis Invasion, angiogenesis [114,115]”
Alexander, S., Weigelin, B., Winkler, F., & Friedl, P. (2013) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2013.07.001 · Cited by 172
Association of Genetic Polymorphisms in the VEGF Gene with Breast Cancer Survival
Lu, H., Shu, X., Cui, Y., Kataoka, N., Wen, W., Cai, Q., Ruan, Z.-X., Gao, Y., & Zheng, W. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-2786 · Cited by 151
“Thus, tumor-induced angiogenesis plays a pivotal role in cancer progression and metastasis (1, 2).”
BackgroundCancer Cell Invasion: Treatment and Monitoring Opportunities in Nanomedicine
Veiseh, O., Kievit, F. M., Ellenbogen, R. G., & Zhang, M. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.01.010 · Cited by 159
“In cancer, angiogenesis occurs when a tumor becomes too large to rely on diffusion for nutrient and oxygen exchange [30].”
BackgroundTumor endothelial marker 1 ( Tem1 ) functions in the growth and progression of abdominal tumors
Nanda, A., Karim, B. O., Peng, Z., Liu, G., Qiu, W., Gan, C. M., Vogelstein, B., Croix, B. S., Kinzler, K. W., & Huso, D. L. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0511306103 · Cited by 151
Angiogenesis is involved in the pathogenesis of nonrheumatic aortic valve stenosis
Soini, Y., Salo, T. A., & Satta, J. (2003) · Human Pathology · doi:10.1016/s0046-8177(03)00245-4 · Cited by 151
Broggini, M., Marchini, S., Galliera, E., Borsotti, P., Taraboletti, G., Erba, E., Sironi, M., Jimeno, J. M., Faircloth, G. T., Giavazzi, R., et al. (2003) · Leukemia · doi:10.1038/sj.leu.2402788 · Cited by 151
Takahashi, N., Haba, A., Matsuno, F., & Seon, B. K. (2001) · PubMed · Cited by 150
Intratumoral Myeloid Cells Regulate Responsiveness and Resistance to Antiangiogenic Therapy
Rivera, L. B., Meyronet, D., Hervieu, V., Frederick, M. J., Bergsland, E., & Bergers, G. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.03.055 · Cited by 147
“…state and increased T-cell infiltration into tumors by creating an even distribution of patent vessels which reduced tumor hypoxia (Carmeliet and Jain, 2000), while genetic deletion of Rgs5 in pericytes increased T-cell infiltration into tumors and enhanced survival after adoptive…”
Wang, S., Liu, S., Sun, H., Huang, T., Chan, C.-H., Yang, C., Yeh, H., Huang, Y., Chou, W., Lin, Y., et al. (2014) · Carcinogenesis · doi:10.1093/carcin/bgu218 · Cited by 156
“In angiogenic processes, endothelial cells must undergo migration, proliferation and tube formation to form tumor neovessel (18).”
BackgroundBerbeco, R. I., Ngwa, W. F., & Makrigiorgos, G. M. (2010) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2010.10.022 · Cited by 157
Cancer-associated Fibroblasts Promote Irradiated Cancer Cell Recovery Through Autophagy
Wang, Y., Gan, G., Wang, B., Wu, J., Cao, Y., Zhu, D., Xu, Y., Wang, X., Han, H., Li, X., et al. (2017) · EBioMedicine · doi:10.1016/j.ebiom.2017.02.019 · Cited by 144
“The initiation and progression of tumors are controlled not only by tumor cells but also by their surrounding stromal cells (Lengauer et al., 1998; Ronnov-Jessen et al., 1996; Tlsty, 2001; Carmeliet and Jain, 2000; Sandler et al., 2004).”
BackgroundArafah, A. M., Rehman, M. U., Mir, T. M., Wali, A. F., Ali, R., Qamar, W., Khan, R., Ahmad, A., Aga, S. S., Alqahtani, S., et al. (2020) · Plants · doi:10.3390/plants9121784 · Cited by 168
“Naringenin exhibits its angio-inhibitory effect by decreasing vascular endothelial growth factor (VGFG) and downregulating the TGF-β pathway, thereby decreasing metastasis and invasion in pancreatic cells.”
BackgroundMonotherapy and Combination Therapy Using Anti‐Angiogenic Nanoagents to Fight Cancer
Liang, P., Ballou, B. T., Lv, X., Si, W., Bruchez, M. P., Huang, W., & Dong, X. (2021) · Advanced Materials · doi:10.1002/adma.202005155 · Cited by 161
Don, A. S., Kisker, O., Dilda, P., Donoghue, N., Zhao, X., Decollogne, S., Creighton, B., Flynn, E., Folkman, J., & Hogg, P. J. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00109-0 · Cited by 150
Man, Y., Wang, P., Guo, Y., Xiang, L., Yang, Y., Qu, Y., Gong, P., & Deng, L. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.08.054 · Cited by 149
“Among these factors, the diffusion limit of oxygen is no far than 200 mm [32].”
BackgroundShibata, M., Iinuma, M., Morimoto, J., Kurose, H., Akamatsu, K., Okuno, Y., Akao, Y., & Otsuki, Y. (2011) · BMC Medicine · doi:10.1186/1741-7015-9-69 · Cited by 149
“Since the growth of both primary tumors and of metastases is angiogenesis-dependent, and since microvascular endothelial cells recruited by a tumor in the process of neovascularization have become an important second target of cancer therapy [40], the antiangiogenic properties of a-mangostin may be very important to t…”
BackgroundRole of tumor vascular architecture in drug delivery
Narang, A. S., & Varia, S. A. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.04.002 · Cited by 162
Pan, S., An, P., Zhang, R., He, X., Yin, G., & Wang, M. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.21.7512-7523.2002 · Cited by 161
“c-Jun(1-80) was visualized by autoradiography.”
BackgroundMethodInfluentialLee, Y. J., Shin, K. J., Park, S.-A., Park, K. S., Park, S., Heo, K., Seo, Y.-K., Noh, D.-Y., Ryu, S. H., & Suh, P.-G. (2016) · Oncotarget · doi:10.18632/oncotarget.12286 · Cited by 144
“Angiogenesis, the process of neo-vessels formation, has a key role in breast cancer growth and progression [35].”
BackgroundTheranostic barcoded nanoparticles for personalized cancer medicine
Yaari, Z., da Silva, D., Zinger, A., Goldman, E., Kajal, A., Tshuva, R., Barak, E., Dahan, N., Hershkovitz, D., Goldfeder, M., et al. (2016) · Nature Communications · doi:10.1038/ncomms13325 · Cited by 146
Physiological principles underlying the kidney targeting of renal nanomedicines
Huang, Y., Ning, X., Ahrari, S., Cai, Q., Rajora, N., Saxena, R., Yu, M., & Zheng, J. (2024) · Nature Reviews Nephrology · doi:10.1038/s41581-024-00819-z · Cited by 155
“For instance, solid tumours are in general highly permeable to nanoparticles — even those >100 nm in size — due to the presence of leaky vasculature 12,40,41 through which cancer nano-medicines can passively extravasate.”
Khorana, A. A., Sahni, A., Altland, O. D., & Francis, C. W. (2003) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000090671.56682.d7 · Cited by 149
Hsu, J. Y., & Wakelee, H. A. (2009) · BioDrugs · doi:10.2165/11317600-000000000-00000 · Cited by 165
“Other mechanisms of tumor angiogenesis include co-option of neighboring vessels, intussusceptive microvascular growth, adult vasculogenesis, mosaic vessels, and vascular mimicry.([5]) Effects of VEGF pathway blockade include inhibition of new vessel growth, endothelial cell apoptosis, and inhibition of endothelial pro…”
BackgroundVelazquez, O. C., Snyder, R., Liu, Z., Fairman, R. M., & Herlyn, M. (2002) · The FASEB Journal · doi:10.1096/fj.01-1011fje · Cited by 145
“Mouse monoclonal antihuman α-smooth muscle actin (clone 1A4 (1)) Ab was obtained from DAKO.”
MethodPhenethyl Isothiocyanate Inhibits Angiogenesis In vitro and Ex vivo
Xiao, D., & Singh, S. V. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3645 · Cited by 158
“of cancer cells leading to metastasis to distant organs (3, 4).”
Metadata
- Authors
- Carmeliet, P., & Jain, R. K.
- Affiliations
- Vlaams Instituut voor Biotechnologie (BE)
- Harvard University (US)
- ORCID
- Carmeliet, Peter
- Venue
- Nature
- Published
- 2000-09
- Volume
- 407
- Issue
- 6801
- Pages
- 249-257
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1573363574
- Cited by
- 9,070
- References
- 72
- Citations by year
- 2026: 166 · 2025: 208 · 2024: 246 · 2023: 330 · 2022: 335 · 2021: 381 · 2020: 368 · 2019: 349 · 2018: 375 · 2017: 380 · 2016: 378 · 2015: 364 · 2014: 414 · 2013: 412 · 2012: 416
- FWCI
- 19.82
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- National Institutes of Health
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Health Sciences › Medicine › Oncology › Lymphatic System and Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Keywords
- pathological angiogenesis, cancer, ischemic diseases, inflammatory diseases, anti-angiogenic therapy, clinical trials
- MeSH terms
- Animals, Disease, Humans, Lymphokines, Neoplasms, Neovascularization, Pathologic, Endothelial Growth Factors, Vascular Endothelial Growth Factors, Vascular Endothelial Growth Factor A
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.